Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1994 1
1995 1
1996 1
1997 1
1998 3
1999 3
2000 3
2001 5
2002 2
2003 2
2006 2
2008 4
2009 4
2010 5
2011 1
2012 3
2013 3
2014 1
2015 5
2016 3
2017 4
2018 6
2019 4
2020 6
2021 10
2022 12
2023 11
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

102 results

Results by year

Filters applied: . Clear all
Page 1
Mucosal adjuvants.
Harandi AM, Medaglini D. Harandi AM, et al. Among authors: medaglini d. Curr HIV Res. 2010 Jun;8(4):330-5. doi: 10.2174/157016210791208695. Curr HIV Res. 2010. PMID: 20353395 Review.
Ebola vaccine R&D: Filling the knowledge gaps.
Medaglini D, Harandi AM, Ottenhoff TH, Siegrist CA; VSV-Ebovac Consortium. Medaglini D, et al. Sci Transl Med. 2015 Dec 9;7(317):317ps24. doi: 10.1126/scitranslmed.aad3106. Sci Transl Med. 2015. PMID: 26659569 Free PMC article. Review.
Characterization of nanoparticles-based vaccines for COVID-19.
Guerrini G, Magrì D, Gioria S, Medaglini D, Calzolai L. Guerrini G, et al. Among authors: medaglini d. Nat Nanotechnol. 2022 Jun;17(6):570-576. doi: 10.1038/s41565-022-01129-w. Epub 2022 Jun 16. Nat Nanotechnol. 2022. PMID: 35710950 Review.
Antibody responses to recombinant vesicular stomatitis virus-Zaire Ebolavirus vaccination for Ebola virus disease across doses and continents: 5-year durability.
Huttner A, Agnandji ST, Engler O, Hooper JW, Kwilas S, Ricks K, Clements TL, Jonsdottir HR, Nakka SS, Rothenberger S, Kremsner P, Züst R, Medaglini D, Ottenhoff T, Harandi AM, Siegrist CA; VEBCON; VSV-EBOVAC; VSV-EBOPLUS Consortia. Huttner A, et al. Among authors: medaglini d. Clin Microbiol Infect. 2023 Dec;29(12):1587-1594. doi: 10.1016/j.cmi.2023.08.026. Epub 2023 Sep 3. Clin Microbiol Infect. 2023. PMID: 37661067
Vaccination in the elderly: The challenge of immune changes with aging.
Ciabattini A, Nardini C, Santoro F, Garagnani P, Franceschi C, Medaglini D. Ciabattini A, et al. Among authors: medaglini d. Semin Immunol. 2018 Dec;40:83-94. doi: 10.1016/j.smim.2018.10.010. Semin Immunol. 2018. PMID: 30501873 Free article. Review.
Role of the Microbiota in the Modulation of Vaccine Immune Responses.
Ciabattini A, Olivieri R, Lazzeri E, Medaglini D. Ciabattini A, et al. Among authors: medaglini d. Front Microbiol. 2019 Jul 3;10:1305. doi: 10.3389/fmicb.2019.01305. eCollection 2019. Front Microbiol. 2019. PMID: 31333592 Free PMC article. Review.
Human neutralizing antibodies to cold linear epitopes and subdomain 1 of the SARS-CoV-2 spike glycoprotein.
Bianchini F, Crivelli V, Abernathy ME, Guerra C, Palus M, Muri J, Marcotte H, Piralla A, Pedotti M, De Gasparo R, Simonelli L, Matkovic M, Toscano C, Biggiogero M, Calvaruso V, Svoboda P, Cervantes Rincón T, Fava T, Podešvová L, Shanbhag AA, Celoria A, Sgrignani J, Stefanik M, Hönig V, Pranclova V, Michalcikova T, Prochazka J, Guerrini G, Mehn D, Ciabattini A, Abolhassani H, Jarrossay D, Uguccioni M, Medaglini D, Pan-Hammarström Q, Calzolai L, Fernandez D, Baldanti F, Franzetti-Pellanda A, Garzoni C, Sedlacek R, Ruzek D, Varani L, Cavalli A, Barnes CO, Robbiani DF. Bianchini F, et al. Among authors: medaglini d. Sci Immunol. 2023 Mar 17;8(81):eade0958. doi: 10.1126/sciimmunol.ade0958. Epub 2023 Mar 10. Sci Immunol. 2023. PMID: 36701425 Free PMC article.
102 results